A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

A new vaccine designed to combat cancer cells in patients with colorectal and pancreatic cancer showed promising results in ...

A groundbreaking pancreatic cancer vaccine shows promise in preventing recurrence, offering new hope for one of the deadliest cancers with historically low survival rates.

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back ...

Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

Black and Hispanic people are more likely to be diagnosed with pancreatic cancer and more likely to die from it. Now, one drug may help fix this.

Cancer rates in 2025 are predicted to exceed the previous year's statistics, with one-in-three men and women both at risk of contracting the disease.

A new vaccine has shown promise in preventing pancreatic and colorectal cancer recurrence Read on to know about the study ...

A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The ...